Federal Register Notice: FDA will hold a public workshop 4/21 entitled “Clinical Considerations of Risk in the Postmarket Environment.” Its purpose is to provide a forum for discussion on assessing changes in medical device risk as quality and safety situations arise in the postmarket setting when a patient, operator, or member of the public uses the device. The workshop will be held 4/21, from 8:30 a.m. to 5 p.m. at FDA’s White Oak Campus, 10903 New Hampshire Ave., Building 31 Conference Center, the Great Room (Rm. 1503), Silver Spring, MD. Contact Jean M. Cooper, (301) 796-6141, email: Jean.Cooper@fda.hhs.gov. To register for the public workshop, visit http://www.fda.gov/MedicalDevices/NewsEvents/WorkshopsConferences/default.htm. To view this notice, click here.